1. Home
  2. SGML vs ABCL Comparison

SGML vs ABCL Comparison

Compare SGML & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sigma Lithium Corporation

SGML

Sigma Lithium Corporation

HOLD

Current Price

$12.75

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$7.87

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGML
ABCL
Founded
2011
2012
Country
Canada
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
SGML
ABCL
Price
$12.75
$7.87
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$18.75
$8.40
AVG Volume (30 Days)
2.2M
7.1M
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$272.11
N/A
Revenue Next Year
$36.70
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$4.62
$2.75
52 Week High
$24.48
$8.42

Technical Indicators

Market Signals
Indicator
SGML
ABCL
Relative Strength Index (RSI) 40.67 73.27
Support Level $10.98 $3.32
Resistance Level $13.37 N/A
Average True Range (ATR) 0.89 0.53
MACD -0.09 0.24
Stochastic Oscillator 24.85 83.58

Price Performance

Historical Comparison
SGML
ABCL

About SGML Sigma Lithium Corporation

Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: